Literature DB >> 11818195

The (in)efficiency of cervical screening in Europe.

A B Miller.   

Abstract

Mesh：

Year:  2002        PMID： 11818195     DOI： 10.1016/s0959-8049(01)00374-4

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  7 in total

1.  Epidemiological aspects of cancer screening in Germany.

Authors:  Nikolaus Becker
Journal:  J Cancer Res Clin Oncol       Date:  2003-10-14       Impact factor: 4.553

2.  Effect of pay-for-performance on cervical cancer screening participation in France.

Authors:  Panayotis Constantinou; Jonathan Sicsic; Carine Franc
Journal:  Int J Health Econ Manag       Date:  2016-12-22

3.  Impact of opportunistic testing in a systematic cervical cancer screening program: a nationwide registry study.

Authors:  Mette Tranberg; Mette Bach Larsen; Ellen M Mikkelsen; Hans Svanholm; Berit Andersen
Journal:  BMC Public Health       Date:  2015-07-21       Impact factor: 3.295

4.  Market survey predictions on the future of US Pap testing.

Authors:  R Marshall Austin; Barbara Benstein; Joel Bentz; Sandra Bigner; Gregory G Freund; Gregory La Rocco; Ibrahim Ramzy; Lynnette Savaloja; Vinod B Shidham
Journal:  Cytojournal       Date:  2009-09-18       Impact factor: 2.091

5.  Reduced cervical cancer incidence and mortality in Canada: national data from 1932 to 2006.

Authors:  James A Dickinson; Agata Stankiewicz; Cathy Popadiuk; Lisa Pogany; Jay Onysko; Anthony B Miller
Journal:  BMC Public Health       Date:  2012-11-16       Impact factor: 3.295

6.  Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort.

Authors:  J Peto; C Gilham; J Deacon; C Taylor; C Evans; W Binns; M Haywood; N Elanko; D Coleman; R Yule; M Desai
Journal:  Br J Cancer       Date:  2004-08-31       Impact factor: 7.640

7.  Attendance at cervical cancer screening and use of diagnostic and therapeutic procedures on the uterine cervix assessed from individual health insurance data (Belgium, 2002-2006).

Authors:  Marc Arbyn; Valérie Fabri; Marleen Temmerman; Cindy Simoens
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.